Atlas Trials

Avelumab as Single Agent in Metastatic or Locally Advanced Urothelial Cancer in Patients Unfit for Cisplatin. The ARIES Study

Clinical trial NCT03891238 · COMPLETED

Trial details

NCT number
NCT03891238
Sponsor
Consorzio Oncotech
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic or Locally Advanced PD-L1 Positive Urothelial Cancer
Start date
2019-02-06
Primary completion
2021-09-15
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.